| Amphotericin B formulations and drug targeting JJ Torrado, R Espada, MP Ballesteros, S Torrado-Santiago Journal of pharmaceutical sciences 97 (7), 2405-2425, 2008 | 355 | 2008 |
| Therapeutic actions of insulin-like growth factor I on APP/PS2 mice with severe brain amyloidosis E Carro, JL Trejo, A Gerber, H Loetscher, J Torrado, F Metzger, ... Neurobiology of aging 27 (9), 1250-1257, 2006 | 192 | 2006 |
| Preparation, dissolution and characterization of albendazole solid dispersions S Torrado, S Torrado, JJ Torrado, R Cadórniga International journal of pharmaceutics 140 (2), 247-250, 1996 | 151 | 1996 |
| Effect of aggregation state on the toxicity of different amphotericin B preparations R Espada, S Valdespina, C Alfonso, G Rivas, MP Ballesteros, JJ Torrado International Journal of Pharmaceutics 361 (1-2), 64-69, 2008 | 134 | 2008 |
| The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs K Daniel-Mwambete, S Torrado, C Cuesta-Bandera, F Ponce-Gordo, ... International journal of pharmaceutics 272 (1-2), 29-36, 2004 | 134 | 2004 |
| Preparation and characterization of albendazole β-cyclodextrin complexes JA Castillo, J Palomo-Canales, JJ Garcia, JL Lastres, F Bolas, JJ Torrado Drug development and industrial pharmacy 25 (12), 1241-1248, 1999 | 123 | 1999 |
| Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles DR Serrano, A Lalatsa, MA Dea-Ayuela, PE Bilbao-Ramos, NL Garrett, ... Molecular pharmaceutics 12 (2), 420-431, 2015 | 121 | 2015 |
| Effect of different excipients on the tableting of coated particles JJ Torrado, LL Augsburger International journal of pharmaceutics 106 (2), 149-155, 1994 | 103 | 1994 |
| Influence of CYP2C8 and CYP2C9 polymorphisms on pharmacokinetic and pharmacodynamic parameters of racemic and enantiomeric forms of ibuprofen in healthy volunteers R López-Rodríguez, J Novalbos, S Gallego-Sandín, M Román-Martínez, ... Pharmacological research 58 (1), 77-84, 2008 | 93 | 2008 |
| Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres JA Sanchez-Brunete, MA Dea, S Rama, F Bolas, JM Alunda, R Raposo, ... Antimicrobial agents and chemotherapy 48 (9), 3246-3252, 2004 | 87 | 2004 |
| New amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania spp HK Ruiz, DR Serrano, MA Dea-Ayuela, PE Bilbao-Ramos, ... International journal of pharmaceutics 473 (1-2), 148-157, 2014 | 85 | 2014 |
| Investigation on the possibility of biowaivers for ibuprofen C Álvarez, I Núñez, JJ Torrado, J Gordon, H Potthast, A García-Arieta Journal of pharmaceutical sciences 100 (6), 2343-2349, 2011 | 83 | 2011 |
| Particle size and size distribution of albumin microspheres produced by heat and chemical stabilization JJ Torrado, L Illum, SS Davis International journal of pharmaceutics 51 (1), 85-93, 1989 | 81 | 1989 |
| Hemolytic and pharmacokinetic studies of liposomal and particulate amphotericin B formulations DR Serrano, L Hernández, L Fleire, I González-Alvarez, A Montoya, ... International journal of pharmaceutics 447 (1-2), 38-46, 2013 | 79 | 2013 |
| Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole JJ Garcı́a, F Bolás, JJ Torrado International Journal of Pharmaceutics 250 (2), 351-358, 2003 | 78 | 2003 |
| In vitro effect of new formulations of amphotericin B on amastigote and promastigote forms of Leishmania infantum L Ordónez-Gutiérrez, R Espada-Fernández, MA Dea-Ayuela, JJ Torrado, ... International Journal of Antimicrobial Agents 30 (4), 325-329, 2007 | 77 | 2007 |
| Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration C Carrascosa, I Torres-Aleman, C Lopez-Lopez, E Carro, L Espejo, ... Biomaterials 25 (4), 707-714, 2004 | 68 | 2004 |
| Quantitative determination of albendazole and its main metabolites in plasma JJ Garcia, F Bolás-Fernández, JJ Torrado Journal of Chromatography B: Biomedical Sciences and Applications 723 (1-2 …, 1999 | 68 | 1999 |
| Effect of c-Sterilization Process on PLGA Microspheres Loaded with Insulin-Like Growth Factor-I (IGF-I) C Carrascosa, L Espejo, S Torrado, JJ Torrado Journal of biomaterials applications 18 (2), 95-108, 2003 | 65 | 2003 |
| Amphotericin B molecular organization as an essential factor to improve activity/toxicity ratio in the treatment of visceral leishmaniasis JA Sanchez-Brunete, MA Dea, S Rama, F Bolas, JM Alunda, ... Journal of drug targeting 12 (7), 453-460, 2004 | 51 | 2004 |
